Major Depressive Disorder

Oxcarbazepine: Does It Have a Role in Bipolar Disorder?

October 26, 2020

Oxcarbazepine might be considered for patients who you want to treat with carbamazepine for mania (as monotherapy or adjunct) but for whom it would be unsafe or who have been unable to tolerate it.

Managing Distress in Health Care Workers During COVID-19: Lessons From a Disaster Trauma Lens

October 19, 2020

We have learned that in order to provide much-needed social support during difficult times, organizations should prepare to take certain steps.

7 Steps to Alleviating Election Anxiety

October 17, 2020

The physical and psychological symptoms of anxiety, such as feeling tense or having trouble concentrating, can be so uncomfortable that they cause behavioral changes. How might these components play out in, say, a Presidential election?

Anticipated Phase 3 Interim Results for Sage’s Depression Treatment, Zuranalone

October 15, 2020

Read about the new results from Sage’s clinical study of depression treatment, zuranolone.

Is the Country Experiencing a Mental Health Pandemic?

October 13, 2020

There are epidemiological and clinical reasons why we should drop that term.

Using the New Indication for Esketamine to Treat Patients with Major Depressive Disorder

October 07, 2020

Dr Sanacora discusses the new indication for esketamine, SPRAVATO®, and how it might be used to treat patients with Major Depressive Disorder with acute risk of suicide ideation.

Treatment Challenges for College Psychiatrists and Their Patients

October 06, 2020

The pandemic has brought into focus treatment barriers, disruption in care, and possibly negative outcomes in the mental health of university students. To better understand the specific challenges of out-of-state students, the authors conducted an anonymous national survey of college psychiatrists.